Metformin / Pioglitazone Uses, Dosage, Side Effects and Interactions
Actoplus Met
Actoplus Met was the first metformin / pioglitazone product the FDA approved, in August 2005. An FDA-approved generic with the same active ingredients is listed.
Actoplus Met XR
Actoplus Met XR came 3 years after Actoplus Met (May 2009) as an extended-release tablet, a form not listed for Actoplus Met. An FDA-approved generic with the same active ingredients is listed.
Metformin / Pioglitazone is a two-medicine tablet used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
Quick links
Ask Anything About Metformin / PioglitazoneType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Metformin / Pioglitazone in Short
- Drug classes Biguanide; Peroxisome Proliferator-activated Receptor alpha Agonist; Peroxisome Proliferator-activated Receptor gamma Agonist; Thiazolidinedione How the FDA classifies it
What it treatsMetformin / Pioglitazone tablets are used along with diet and exercise to improve blood sugar (glycemic) control in adults with type 2 diabetes. This applies to all the supported products, including Actoplus Met and the generic pioglitazone and metformin hydrochloride tablets.
- How you get it Prescription only
- Comes asTablet (by mouth)
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- What pharmacies pay
- Generic$0.24 to $0.32 a tablet
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Metformin / pioglitazone combines two type 2 diabetes medicines in one tablet: metformin cuts the sugar your liver releases, and pioglitazone helps your body respond to its own insulin. It is usually a convenience option for people already taking one or both, and it has been on the U.S. market since about 2005, with FDA-approved generics listed. Most people do fine on it, though metformin can loosen stools early on and pioglitazone often adds some weight and ankle swelling. Its boxed warning covers heart failure and lactic acidosis (a rare, dangerous acid buildup), so get help promptly for rapid weight gain, breathlessness, worsening swelling, or unusual muscle pain, sleepiness and stomach pain.
Key Takeaways From the HelloPharmacist Team
- Take it with meals, once or twice a day as prescribed, because food softens the stomach upset metformin can cause.
- Give it several weeks to show its full effect, because pioglitazone lowers blood sugar gradually rather than right away.
- Expect kidney and liver blood tests before you start and regular kidney checks after, more often if you are 65 or older.
- Keep alcohol light, and ask about pausing it before contrast-dye scans, surgery, or any stretch when you cannot eat or drink.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Metformin / Pioglitazone.
This medicine can cause or worsen heart failure and can cause a rare but life-threatening condition called lactic acidosis.
Heart failure: Pioglitazone can make your body hold fluid. Watch for rapid weight gain, shortness of breath, or swelling. Tell your doctor right away if these appear. It should not be started if you have severe (Class III or IV) heart failure.
Lactic acidosis: Metformin can lead to a dangerous buildup of lactic acid. Early signs can be vague, such as feeling unwell, muscle aches, trouble breathing, unusual sleepiness, or stomach pain. Risk is higher with kidney or liver problems, age 65 or older, heavy alcohol use, contrast-dye imaging, surgery, low oxygen states, mitochondrial disease, and some other medicines. If you suspect it, stop the medicine and get hospital care right away.
Patient Information Guide for Metformin / Pioglitazone
What It’s Used For
Metformin / Pioglitazone is a combination tablet used for one main purpose.
- Improving blood sugar control in adults with type 2 diabetes, along with diet and exercise (Actoplus Met and the generic pioglitazone and metformin hydrochloride tablets).
- It is not recommended for type 1 diabetes or diabetic ketoacidosis.
How It Works
Pioglitazone makes your body more responsive to insulin and lowers sugar released by the liver. It works through a receptor called PPAR-gamma found in fat, muscle and liver, and needs insulin to be present to work.
Metformin lowers liver sugar production, reduces sugar absorbed from the gut, and improves how muscles use sugar. It does not raise insulin levels.
Drug Class
Drug Class
- Peroxisome Proliferator-activated Receptor alpha Agonist from pioglitazone
- Peroxisome Proliferator-activated Receptor gamma Agonist from pioglitazone
- Thiazolidinedione from pioglitazone
- Biguanide from metformin
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Metformin / Pioglitazone has two active ingredients, so each class says which one it comes from.
Drug Class
Established Pharmacologic Class (EPC)- Peroxisome Proliferator-activated Receptor alpha Agonist from pioglitazone
- Peroxisome Proliferator-activated Receptor gamma Agonist from pioglitazone
- Thiazolidinedione from pioglitazone
- Biguanide from metformin
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Peroxisome Proliferator-activated Receptor alpha Agonists from pioglitazone
- Peroxisome Proliferator-activated Receptor gamma Agonists from pioglitazone
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Metformin / Pioglitazone in the FDA’s index.
From our Patient Information GuidePioglitazone makes your body more responsive to insulin and lowers sugar released by the liver. It works through a receptor called PPAR-gamma found in fat, muscle and liver, and needs insulin to be present to work. Metformin lowers liver sugar production, reduces sugar absorbed from the gut, and improves how muscles use sugar. Read How Metformin / Pioglitazone Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Thiazolidinediones from pioglitazone
- Biguanides from metformin
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Combinations of oral blood glucose lowering drugs
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
These tablets are taken by mouth with meals to ease stomach side effects. Your prescriber individualizes your starting dose and raises it gradually based on response and tolerability.
- Liver tests and kidney function (eGFR) should be checked before you start.
- If you miss a dose, do not double the next one.
- Follow your prescriber and your label for the exact dose.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Not treated with either pioglitazone or metformin hydrochloride, starting dosage
For adults not taking pioglitazone or metformin · Starting dose
Dose 15 mg of pioglitazone
- One tablet (15 mg of pioglitazone and 850 mg of metformin hydrochloride per tablet) orally once daily
Currently treated with metformin hydrochloride, starting dosage
For adults already taking metformin · Starting dose
Dose 15 mg of pioglitazone
- One tablet (15 mg of pioglitazone and 850 mg of metformin hydrochloride per tablet) orally once or twice daily.
- Select a dosage that is as close as possible to the current dosage of metformin hydrochloride
Currently treated with pioglitazone, starting dosage
For adults already taking pioglitazone · Starting dose
Dose 15 mg of pioglitazone
- One tablet (15 mg of pioglitazone and 850 mg of metformin hydrochloride per tablet) orally once daily
Currently treated with pioglitazone and metformin hydrochloride, starting dosage
For adults already taking pioglitazone and metformin · Starting dose
Usual dose 15 mg of pioglitazone
- Select a dosage that is as close as possible to the current dosage of pioglitazone and metformin hydrochloride while not exceeding three tablets orally per day (15 mg of pioglitazone and 850 mg of metformin hydrochloride per tablet)
Also three tablets orally per day
Needing additional glycemic control, dosage titration
For adults · Dose increase
Dose 45 mg of pioglitazone
Highest dose 45 mg of pioglitazone a day
Step by step
- Titrate gradually, as needed, after assessing therapeutic response and tolerability
- May be increased to three tablets per day (45 mg of pioglitazone and 2,550 mg of metformin hydrochloride)
- Total daily dosages of 2,550 mg of metformin hydrochloride may be taken in divided doses three times a day
- three tablets per day (45 mg of pioglitazone and 2,550 mg of metformin hydrochloride)
Good to know
Divided doses three times a day may reduce gastrointestinal adverse reactions
NYHA class I or II congestive heart failure, starting dosage
For adults · Starting dose
Starting dose 15 mg of pioglitazone and 500 mg of metformin, or 15 mg of pioglitazone and 850 mg of metformin, once a day
Good to know
Monitor for fluid retention after initiation and dose increases
Type 2 diabetes (blood sugar control)
For adults also taking gemfibrozil or similar strong CYP2C8 inhibitors
Dose 15 mg of pioglitazone
Highest dose 15 mg of pioglitazone a day
- One tablet (15 mg of pioglitazone and 850 mg of metformin hydrochloride) once daily
Limit one tablet (15 mg of pioglitazone and 850 mg of metformin hydrochloride) once daily
Side Effects
The most common side effects reported are:
Common side effects
- Upper respiratory tract infection (cold-like symptoms)
- Swelling (edema)
- Diarrhea
- Headache
- Weight gain
- Sinus infection
- Muscle pain
- Sore throat
When to get medical help
- Rapid weight gain, shortness of breath, or swelling, which can be signs of heart failure
- Unusual muscle pain, weakness, feeling very tired, trouble breathing, unusual sleepiness, or stomach pain, which can signal lactic acidosis (a dangerous buildup of lactic acid). Stop the medicine and get medical help right away
- Fatigue, poor appetite, pain in the upper right belly, dark urine, or yellowing of the skin or eyes, which can signal liver problems
- Sudden vision changes, which can signal macular edema (swelling in the back of the eye)
- Blood in your urine or other bladder symptoms, since bladder cancer risk has been raised as a concern
- Signs of low blood sugar if you also take insulin or a sulfonylurea
- Bone fractures, which are more common in women taking pioglitazone
Warnings and Precautions
- Heart failure: pioglitazone can cause fluid retention that causes or worsens heart failure. Watch for fast weight gain, shortness of breath, and swelling.
- Lactic acidosis: metformin can cause this dangerous buildup, especially with kidney problems, liver disease, age 65 or older, heavy alcohol use, or low oxygen states.
- Liver effects: liver failure, sometimes fatal, has been reported with pioglitazone. Liver tests are checked before starting.
- Bladder cancer: it may raise the risk. Do not use with active bladder cancer.
- Fractures: more common in women.
- Macular edema: regular eye exams are recommended.
- Vitamin B12: metformin may lower levels, so blood is checked periodically.
- Contrast dye and surgery: the medicine may need to be paused.
Interactions
Several medicines and substances can change how this tablet works or raise its risks.
- Gemfibrozil (strong CYP2C8 inhibitor): raises pioglitazone levels, so the dose is limited.
- Rifampin: may lower pioglitazone levels.
- Topiramate and other carbonic anhydrase inhibitors: may raise lactic acidosis risk.
- Ranolazine, vandetanib, dolutegravir, cimetidine: can cause metformin to accumulate.
- Alcohol: raises lactic acidosis risk.
- Insulin or sulfonylureas: raise low blood sugar risk.
- Steroids, thiazide diuretics, estrogens and others: can raise blood sugar.
Interactions Listed in the FDA-Approved Label
From the Metformin / Pioglitazone prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Strong CYP2C8 inhibitors For example: gemfibrozilWhat happensSignificantly increase pioglitazone exposure (AUC) and half-life.What to doLimit to 15 mg of pioglitazone and 850 mg of metformin HCl once daily.
-
CYP2C8 inducers For example: rifampinWhat happensMay significantly decrease pioglitazone exposure (AUC).What to doIf an inducer is started or stopped, changes in diabetes treatment may be needed based on clinical response, without exceeding 45 mg of pioglitazone and 2,550 mg of metformin HCl.
-
Carbonic anhydrase inhibitors (topiramate, zonisamide, acetazolamide, dichlorphenamide)What happensFrequently decrease serum bicarbonate and may increase the risk of lactic acidosis.What to doConsider more frequent monitoring.
-
Drugs that reduce metformin clearance (ranolazine, vandetanib, dolutegravir, cimetidine)What happensCould increase systemic exposure to metformin and may increase the risk of lactic acidosis.What to doConsider the benefits and risks of concomitant use.
-
AlcoholWhat happensPotentiates the effect of metformin on lactate metabolism.What to doWarn patients against excessive alcohol intake.
-
Insulin secretagogues (e.g., sulfonylurea) or insulinWhat happensMay increase the risk of hypoglycemia.What to doIf hypoglycemia occurs with an insulin secretagogue, reduce the dose of the insulin secretagogue.
-
Drugs affecting glycemic control (thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers, isoniazid)What happensTend to produce hyperglycemia and may lead to loss of glycemic control.What to doObserve closely for loss of blood glucose control when given; observe closely for hypoglycemia when withdrawn.
-
What happensDecreases exposure of pioglitazone and its active metabolites; clinical relevance unknown.What to doMonitor patients for adequate glycemic control.
Read the label’s full interactions text
7 DRUG INTERACTIONS • Strong CYP2C8 inhibitors (e.g., gemfibrozil): Limit pioglitazone and metformin hydrochloride dose to 15 mg/850 mg daily. • CYP2C8 inducers (e.g., rifampin) may decrease pioglitazone concentrations. • Carbonic anhydrase inhibitors may increase risk of lactic acidosis. Consider more frequent monitoring. • Drugs that reduce metformin clearance (such as ranolazine, vandetanib, dolutegravir, and cimetidine), may increase the accumulation of metformin. Consider the benefits and risks of concomitant use. • Alcohol: Warn patients against excessive alcohol intake. • Use of insulin secretagogues or insulin use may increase the risk for hypoglycemia and may require dose reduction. • Topiramate may decrease pioglitazone concentrations. 7.1 Strong CYP2C8 Inhibitors An inhibitor of CYP2C8 (e.g., gemfibrozil) significantly increases the exposure (area under the serum concentration-time curve or AUC) and half-life (t 1/2 ) of pioglitazone. Therefore, the maximum recommended dosage of pioglitazone and metformin hydrochloride tablets is 15 mg of pioglitazone and 850 mg of metformin HCl once daily if used in combination with gemfibrozil or other strong CYP2C8 inhibitors. 7.2 CYP2C8 Inducers An inducer of CYP2C8 (e.g., rifampin) may significantly decrease the exposure (AUC) of pioglitazone. Therefore, if an inducer of CYP2C8 is started or stopped during treatment with pioglitazone and metformin hydrochloride tablets, changes in diabetes treatment may be needed based on clinical response without exceeding the maximum recommended daily dosage of pioglitazone and metformin hydrochloride tablets, (45 mg of pioglitazone and 2,550 mg of metformin HCl).
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Not for people with established Class III or IV heart failure, severe kidney impairment (eGFR below 30), metabolic acidosis, or a serious allergy to its ingredients.
- Not recommended with symptomatic heart failure, liver disease, or mitochondrial disease.
- Use caution with edema, or a history of bladder cancer.
- Pregnancy: data are limited. Tell your doctor if you are pregnant or planning pregnancy. It may cause ovulation in some women who were not ovulating.
- Breastfeeding: metformin is present in human milk, so discuss with your doctor.
- Children: not recommended.
- Older adults: kidney function should be checked more often.
Overdose
In metformin overdose, lactic acidosis occurred in about 32% of cases, and low blood sugar was reported in about 10%. Hemodialysis may help remove metformin. If you suspect an overdose, call Poison Help at 1-800-222-1222 or seek emergency care.
How Your Body Processes It
The combination tablet delivers pioglitazone and metformin at levels equivalent to taking them separately. Food slightly delays absorption, but this is not likely to matter clinically. Pioglitazone is heavily metabolized by the liver and mostly leaves through bile and stool. Metformin is not metabolized and is cleared unchanged by the kidneys, which is why kidney problems raise the risk of buildup.
Storage
Store at 20º to 25º C (68º to 77º F); excursions permitted to 15º to 30º C (59º to 86º F) . Protect from moisture and humidity.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Metformin / Pioglitazone: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Metformin / Pioglitazone — the kind of thing our pharmacy team would talk through with you at the counter.
What is this medicine for?
How should I take it?
What side effects should I expect?
When should I get help right away?
Can I drink alcohol while taking it?
Is it safe in pregnancy?
Is metformin / pioglitazone available over the counter?
When was metformin / pioglitazone first available?
Who makes metformin / pioglitazone?
What is the brand name of metformin / pioglitazone?
What is the generic name of Actoplus Met?
What drug class is metformin / pioglitazone?
Is there a generic version of metformin / pioglitazone?
What strengths does metformin / pioglitazone come in?
How much does metformin / pioglitazone cost?
Where can I read the metformin / pioglitazone prescribing information (package insert)?
Is metformin / pioglitazone gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Metformin / Pioglitazone
Skip the scrolling. Ask in your own words and get an answer from Metformin / Pioglitazone’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Metformin / Pioglitazone’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Metformin / Pioglitazone on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Metformin / Pioglitazone Forms and Strengths (How It Comes)
Metformin / Pioglitazone comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Metformin / Pioglitazone inactive ingredients by manufacturer.
Tablet
How this form is used
- Actoplus Met is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
- Pioglitazone and metformin hydrochloride tablets are used the same way and are not for type 1 diabetes or diabetic ketoacidosis.
- Actoplus Met is taken by mouth with meals to reduce stomach side effects from metformin.
- Actoplus Met: if you miss a dose, do not double the next dose.
- Pioglitazone and metformin hydrochloride tablets are also taken by mouth with meals, after liver tests are checked.
Metformin / Pioglitazone on the U.S. Market: Products, Makers and Brands
How Metformin / Pioglitazone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
6 companies list 13 Metformin / Pioglitazone product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2005. Brand names in the directory today include Actoplus Met and Actoplus Met XR; the rest are generics.
Also listed with the FDA, not a patient dose form: Unfinished tablet (2) · Unfinished tablet, film coated (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Metformin / Pioglitazone Is Used (Medicaid Data)
How many Metformin / Pioglitazone prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Metformin / Pioglitazone prescribed? Of the 1,682 medications we measure, Metformin / Pioglitazone ranks #1,154 by Medicaid prescriptions — more than 31% of them.
Utilization by Metformin / Pioglitazone product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
metformin hydrochloride 850 MG / pioglitazone 15 MG Oral Tablet Most dispensed
6 of 27 listed NDCs had Medicaid claims. RxNorm 861822
metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet
3 of 28 listed NDCs had Medicaid claims. RxNorm 861783
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 9 of the 55 listed Metformin / Pioglitazone NDCs had Medicaid claims.
Compare Metformin / Pioglitazone Products
A representative set of FDA-listed product records for Metformin / Pioglitazone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 850 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 850 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| METFORMIN HYDROCHLORIDE 500 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| METFORMIN HYDROCHLORIDE 850 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg | Oral | Macleods Pharmaceuticals Limited | ANDA | View NDC → |
| PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 850 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 850 mg | Oral | Takeda Pharmaceuticals America, Inc. | NDA | View NDC → |
| METFORMIN HYDROCHLORIDE 500 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg | Oral | Torrent Pharmaceuticals Limited | ANDA | View NDC → |
| METFORMIN HYDROCHLORIDE 850 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg | Oral | Torrent Pharmaceuticals Limited | ANDA | View NDC → |
Showing 13 of 13 products — FDA National Drug Code Directory. See every product, package size and price: browse all 13 Metformin / Pioglitazone NDCs →
Metformin / Pioglitazone Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Metformin / Pioglitazone — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Metformin / Pioglitazone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Metformin / Pioglitazone FDA Approval History
How Metformin / Pioglitazone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Metformin / Pioglitazone Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Metformin / Pioglitazone recalls since July 2021.
✅No Metformin / Pioglitazone recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Metformin / Pioglitazone in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.
- Dose forms
- 1
- Strengths
- 2
- Forms in current FDA listings
- 1 of 1
RxCUI 607999 -
Dose form (SCDF) Oral TabletIn current FDA listings
RxCUI 577093Its 2 strengths (SCD)-
metformin hydrochloride 500 mg / pioglitazone 15 mg
RxCUI 861783 -
metformin hydrochloride 850 mg / pioglitazone 15 mg
RxCUI 861822
-
metformin hydrochloride 500 mg / pioglitazone 15 mg
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Metformin / Pioglitazone Supply and Shortage Status
Whether Metformin / Pioglitazone is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Metformin / Pioglitazone Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Metformin / Pioglitazone: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a strength to see how its price has changed since Nov 2023.
For the generic PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 500 mg tablet, pharmacies paid an average of $0.317 per tablet as of Nov 18, 2026, down 24% from $0.415 a year earlier.
- What pharmacies pay now
- $0.317
- per tablet, as of Nov 18, 2026
- Last 4 weeks
- Up 7.7%
- from $0.294 on Oct 21, 2026
- Last 12 months
- Down 24%
- from $0.415 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $0.209 to $0.676
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $0.317 |
| Oct 2026 | $0.294 |
| Sep 2026 | $0.284 |
| Aug 2026 | $0.322 |
| Jul 2026 | $0.377 |
| Jun 2026 | $0.411 |
| May 2026 | $0.410 |
| Apr 2026 | $0.382 |
| Mar 2026 | $0.383 |
| Feb 2026 | $0.377 |
| Jan 2026 | $0.397 |
| Dec 2025 | $0.410 |
| Nov 2025 | $0.415 |
| Oct 2025 | $0.446 |
| Sep 2025 | $0.514 |
| Aug 2025 | $0.567 |
| Jul 2025 | $0.538 |
| Jun 2025 | $0.498 |
| May 2025 | $0.492 |
| Apr 2025 | $0.559 |
| Mar 2025 | $0.556 |
| Feb 2025 | $0.537 |
| Jan 2025 | $0.538 |
| Dec 2024 | $0.598 |
| Nov 2024 | $0.631 |
| Oct 2024 | $0.676 |
| Sep 2024 | $0.618 |
| Aug 2024 | $0.416 |
| Jul 2024 | $0.320 |
| Jun 2024 | $0.209 |
| May 2024 | $0.307 |
| Apr 2024 | $0.412 |
| Mar 2024 | $0.230 |
| Feb 2024 | $0.230 |
| Jan 2024 | $0.230 |
| Dec 2023 | $0.220 |
| Nov 2023 | $0.612 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Tablet · Oral | PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 500 mg | Generic | $0.317 per tablet | NDC details & price history |
| Tablet · Oral | PIOGLITAZONE HYDROCHLORIDE 15 mg/1; METFORMIN HYDROCHLORIDE 850 mg | Generic | $0.239 per tablet | NDC details & price history |
| Tablet · Oral | METFORMIN HYDROCHLORIDE 500 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg | Generic | $0.317 per tablet | NDC details & price history |
| Tablet · Oral | METFORMIN HYDROCHLORIDE 850 mg/1; PIOGLITAZONE HYDROCHLORIDE 15 mg | Generic | $0.239 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Metformin / Pioglitazone Brand Names
Metformin / Pioglitazone has 2 brand names on record: Actoplus Met and Actoplus Met XR. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Metformin / Pioglitazone: Manufacturers and Labelers
6 companies list Metformin / Pioglitazone products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, Aurobindo Pharma Limited, Macleods Pharmaceuticals Limited. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Metformin / Pioglitazone Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Takeda Pharmaceuticals America, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →